Bora Pharmaceuticals announced it has completed the acquisition of Upsher-Smith Laboratories, a generics manufacturer and marketer based in Minnesota, USA.
Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith
read more
News
SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient
SunWay Biotech and Gnosis by Lesaffre has announced a strategic partnership to launch their inaugural product, MenaQ7® Metabolic, featuring the ANKASCIN® 568-R.
Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), today announced that its Board of Directors has approved the acquisition of Upsher-Smith Laboratories, Inc. (“Upsher-Smith”), a generics manufacturer based in Minnesota, US, from shareholders, Sawai Group Holdings Co., Ltd. (JP), and Sumitomo Corporation of Americas, for a total consideration of up to US$210 million.
Bora Pharmaceuticals Celebrates Integration with SunWay Biotech, Embarking on a Global Journey
Taipei, Taiwan – December 11, 2023 – Last Friday, Bora Pharmaceuticals officially embraced SunWay Biotech into the Bora family.